First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study
AIM: To evaluate the efficiency and safety of long-term (12-month) treatment with the endothelin receptor antagonist bosentan (tracleer (Actelion, Switzerland)) in patients with pulmonary hypertension (PH)/MATERIAL AND METHODS: The prospective observational study enrolled 10 patients (8 with idiopat...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Russo |
| יצא לאור: |
"Consilium Medicum" Publishing house
2013-03-01
|
| סדרה: | Терапевтический архив |
| נושאים: | |
| גישה מקוונת: | https://ter-arkhiv.ru/0040-3660/article/view/31217 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|